← FDA DRUG APPROVALS

FDA ANDA · ANDA075791

OMEPRAZOLE

Sponsor: SANDOZ

APPLICATION
ANDA075791
TYPE
ANDA
ORIGINAL APPROVAL
2002-12-23
LATEST ACTION
2002-12-23
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
None (Tentative Approval)

Products

OMEPRAZOLENone (Tentative Approval)
OMEPRAZOLE 20MG · CAPSULE, DELAYED REL PELLETS · ORAL
OMEPRAZOLENone (Tentative Approval)
OMEPRAZOLE 10MG · CAPSULE, DELAYED REL PELLETS · ORAL

Approval history

2002-12-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →